VRAX
Income statement / Annual
Last year (2024), Virax Biolabs Group Limited's total revenue was $156,419.00,
an increase of 1,727.11% from the previous year.
In 2024, Virax Biolabs Group Limited's net income was -$6.73 M.
See Virax Biolabs Group Limited’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
| Operating Revenue |
$156,419.00
|
$8,561.00
|
$0.00
|
$123,820.00
|
$99,876.00
|
| Cost of Revenue |
$105,829.00 |
$9,926.00 |
$0.00 |
$133,254.00 |
$54,127.00 |
| Gross Profit |
$50,590.00 |
-$1,365.00 |
$0.00 |
-$9,434.00 |
$45,749.00 |
| Gross Profit Ratio |
0.32 |
-0.16 |
0 |
-0.08 |
0.46 |
| Research and Development
Expenses |
$1.56 M
|
$397,109.00
|
$433,743.00
|
$120,221.00
|
$87,000.00
|
| General & Administrative
Expenses |
$4.59 M
|
$5.31 M
|
$1.29 M
|
$457,680.00
|
$602,303.00
|
| Selling & Marketing
Expenses |
$0.00
|
$26,616.00
|
$13,818.00
|
$57,203.00
|
$7,690.00
|
| Selling, General &
Administrative Expenses |
$4.59 M
|
$5.33 M
|
$1.30 M
|
$514,883.00
|
$609,993.00
|
| Other Expenses |
$390,355.00 |
$290,466.00 |
$0.00 |
$266.00 |
$2,470.00 |
| Operating Expenses |
$6.55 M |
$5.73 M |
$1.73 M |
$635,104.00 |
$696,993.00 |
| Cost And Expenses |
$6.65 M |
$5.74 M |
$1.73 M |
$768,358.00 |
$751,120.00 |
| Interest Income |
$0.00 |
$15,468.00 |
$15,438.00 |
$28,643.00 |
$90,690.00 |
| Interest Expense |
$26,878.00 |
$15,468.00 |
$15,438.00 |
$28,643.00 |
$90,690.00 |
| Depreciation &
Amortization |
$103,099.00
|
$1.00
|
$1.73 M
|
$644,538.00
|
$651,244.00
|
| EBITDA |
-$6.61 M
|
-$5.44 M
|
-$750.00
|
$0.00
|
-$648,774.00
|
| EBITDA Ratio |
-42.25 |
-669.64 |
0 |
-5.21 |
-6.5 |
| Operating Income Ratio
|
-41.53
|
-669.64
|
0
|
-5.21
|
-6.52
|
| Total Other
Income/Expenses Net |
-$242,647.00
|
$274,998.00
|
-$16,191.00
|
-$28,377.00
|
-$88,220.00
|
| Income Before Tax |
-$6.74 M |
-$5.46 M |
-$1.75 M |
-$672,915.00 |
-$739,464.00 |
| Income Before Tax Ratio
|
-43.08
|
-637.51
|
0
|
-5.43
|
-7.4
|
| Income Tax Expense |
$0.00 |
-$271.00 |
-$1.77 M |
-$666,469.00 |
$61,667.00 |
| Net Income |
-$6.73 M |
-$5.46 M |
-$1.71 M |
-$650,984.00 |
-$801,131.00 |
| Net Income Ratio |
-43.05 |
-637.48 |
0 |
-5.26 |
-8.02 |
| EPS |
-3.36 |
-5.13 |
-1.5 |
-0.57 |
-0.7 |
| EPS Diluted |
-3.36 |
-5.13 |
-1.5 |
-0.57 |
-0.7 |
| Weighted Average Shares
Out |
$2.01 M
|
$1.06 M
|
$1.14 M
|
$1.14 M
|
$1.14 M
|
| Weighted Average Shares
Out Diluted |
$2.01 M
|
$1.06 M
|
$1.14 M
|
$1.14 M
|
$1.14 M
|
| Link |
|
|
|
|
|
